Contract lifecycle management built for life sciences & pharma
Accelerate clinical trial agreements, automate regulatory obligation tracking, and keep every agreement audit-ready across FDA, EMA, GxP and 21 CFR Part 11 — with AI-native CLM and obligation management.
See Aavenir for life sciences
Get a personalized walkthrough for your legal, quality and procurement teams.
Embed your HubSpot form here — takes 30 seconds. No spam, unsubscribe anytime.
Trusted by healthcare & life sciences leaders
Contract lifecycle management (CLM) for life sciences is software that manages pharmaceutical, biotech and medical-device agreements — clinical trial agreements, CDAs, CRO master service agreements and licensing deals — across their full lifecycle, while enforcing regulatory obligations such as 21 CFR Part 11, FDA, EMA and GxP. Aavenir delivers this as AI-native CLM that unifies contracts and the obligations inside them in one audit-ready system of record.
Key takeaways
- ✓Aavenir is AI-native CLM and obligation management, purpose-fit for pharma, biotech and medical-device contracting.
- ✓It accelerates clinical trial agreements and automates obligation tracking so milestones and regulatory commitments are never missed.
- ✓Immutable audit trails and e-signature provide 21 CFR Part 11- and GxP-aligned evidence for audits and litigation defense.
- ✓Customers report up to 5× faster contract cycles; roughly 70% of contract cost and risk occurs post-signature, where Aavenir is strongest.
In life sciences, a contract gap is a compliance event
Pharma and biotech teams manage thousands of high-stakes agreements across sponsors, CROs, sites, suppliers and regulators. When obligations live in spreadsheets and contracts live in inboxes, the cost isn't just slow cycles — it's regulatory exposure, missed milestones and litigation risk.
Regulatory exposureCompliance buried in contract clauses
Without a systematic way to enforce 21 CFR Part 11, FDA, EMA and GxP language across every agreement, a single missing clause can trigger noncompliance, recalls and penalties in the hundreds of millions.
Missed obligationsMilestones tracked in spreadsheets
Milestone payments, reporting commitments and SLA obligations across clinical trials are chased manually. Deadlines slip, deliverables fall through the cracks, and value leaks after signature.
Zero visibilityContracts scattered across the enterprise
Agreements sit in shared drives, email and local folders. When legal needs a CRO term or an audit demands a record, no one can find the authoritative version fast enough.
Speed to marketApproval bottlenecks delay trials
Manual routing and legal back-and-forth stretch turnaround on clinical trial agreements and supplier deals — pushing back trial start dates and slowing therapies to patients.
Litigation & disputesNo defensible audit trail
Disputes over deliverables, IP and indemnities escalate without a single source of truth. Reconstructing who agreed to what — and when — becomes a costly, manual fire drill.
Fragmented stackDisconnected from procurement & QMS
CLM that doesn't talk to procurement, vendor onboarding and quality systems forces duplicate data entry and leaves obligations stranded outside the systems your teams actually work in.
From contract chaos to contract clarity
Aavenir unifies the entire contract lifecycle — and the obligations inside every agreement — on one AI-native platform. Here's how each life-sciences pain point maps to a capability.
Built for the agreements that move your pipeline
Aavenir handles the term-heavy, high-volume, high-risk contract types unique to pharma, biotech and medical device organizations.
Proof, not promises
“Aavenir gave our legal and operations teams one place to author, approve and track every agreement — and the obligations inside them. We accelerated our contract cycle 5× and finally have audit-ready visibility across the board.”
Trusted by legal, procurement & operations leaders
“We cut clinical trial agreement turnaround from weeks to days. Our sites get contracts faster, which means trials start faster.”
“Obligation tracking used to be a spreadsheet nightmare. Now every milestone and reporting commitment is assigned, tracked and closed automatically.”
“Audit prep that took weeks now takes hours. Every version, approval and signature is right there in one defensible record.”
Testimonials shown are illustrative role-based examples for this template and should be replaced with approved customer quotes before publishing.
Go deeper on life sciences CLM
Guides, datasheets and articles for your legal, procurement and operations teams.
The pharma leader's guide to clinical trial agreement automation
How to cut CTA turnaround, standardize terms across sites, and keep every trial audit-ready.
Read more →Obligation management for life sciences: never miss a regulatory commitment
See how AI obligation extraction keeps FDA, EMA and milestone obligations on track.
Read more →21 CFR Part 11 & GxP: what your CLM must prove in an audit
A practical checklist for audit-ready contract records in regulated environments.
Read more →Life sciences CLM questions, answered
What is contract lifecycle management for life sciences? +
How does Aavenir support 21 CFR Part 11 and GxP compliance? +
Can Aavenir automate obligation tracking across clinical trials? +
Which contract types does Aavenir handle for pharma and biotech? +
What's the difference between contract management and obligation management? +
Is Aavenir a good fit for medical device companies? +
Does Aavenir fit our existing technology stack? +
See Aavenir CLM for life sciences in action
Get a personalized walkthrough of how Aavenir accelerates contracts, automates obligations and keeps your organization audit-ready.
- ✓Live walkthrough tailored to your contract types
- ✓See AI obligation extraction on a real agreement
- ✓Talk through 21 CFR Part 11 & GxP audit readiness
See Aavenir for life sciences
Get a personalized walkthrough for your legal, quality and procurement teams.
Embed your HubSpot form here — takes 30 seconds. No spam, unsubscribe anytime.